Clinical Research Studies

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

• Conditions:
  Cerebral Infarction
  Ich
• Age: Between 18 years - 120 years
• Gender: Male or Female

• Other Inclusion Criteria:
  

  1. Have been diagnosed with acute ischemic stroke and have been treated with dabigatran, rivaroxaban, apixaban, edoxaban within 7 days prior to admission, or
  2. Have been diagnosed with intracerebral hemorrhage and have been treated with warfarin or one of the new oral anticoagulants within 7 days prior to admission
  3. ARAMIS PRO follow-up study: Ability of patient or legally authorized representative to provide informed consent for longitudinal follow-up indicating they understand the purpose and the requirements of the study and are willing to participate.

  
  

You may not be eligible for this study if the following are true:

• 1. Patients who were transferred from another hospital or discharged to other acute care facility will be excluded.